bibliographic entry 10166878 [be/10166878]
https://w3id.org/oc/corpus/be/10166878

is a

• bibliographic reference

content

• Buse JB, Garber A, Rosenstock J et al. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials. J Clin Endocrinol Metab 2011; 96: 1695–1702. PMID: 21450987

references

• https://w3id.org/oc/corpus/br/1227380